- Lean about the benefits and limitations of quantitative multiplex immunofluorescence (qmIF) technology
- Find out how qmIF is used to stage patients with melanoma
- Discover how qmIF can lead to better treatment stratification of patients with melanoma
- Have the opportunity to ask questions during the live broadcast.
Speaker: Yvonne Saenger, M.D., Columbia University Herbert Irving Comprehensive Cancer Center